English

Eligibility Criteria

5 forms  
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. Subject ID and consent group of participants in mid-secretory endometrium, corresponding to the luteal phase of the ovarian cycle and involved in the "Expression Quantitative Trait Locus Mapping Studies in Mid-Secretory Phase Endometrial Cells Identifies HLA-F and TAP2 as Fecundability-Associated Genes" project.
    3. Subject ID, sample ID, and sample use variable obtained from participants in mid-secretory endometrium, corresponding to the luteal phase of the ovarian cycle and involved in the "Expression Quantitative Trait Locus Mapping Studies in Mid-Secretory Phase Endometrial Cells Identifies HLA-F and TAP2 as Fecundability-Associated Genes" project.
    4. Subject ID, age, BMI, race, number of previous miscarriages at time of endometrial biopsy, and time of year of endometrial biopsy of participants in mid-secretory endometrium, corresponding to the luteal phase of the ovarian cycle and involved in the "Expression Quantitative Trait Locus Mapping Studies in Mid-Secretory Phase Endometrial Cells Identifies HLA-F and TAP2 as Fecundability-Associated Genes" project.
    5. Sample ID, genotyping center, body site where sample was obtained, analyte type, and tumor status of samples obtained from participants in mid-secretory endometrium, corresponding to the luteal phase of the ovarian cycle and involved in the "Expression Quantitative Trait Locus Mapping Studies in Mid-Secretory Phase Endometrial Cells Identifies HLA-F and TAP2 as Fecundability-Associated Genes" project.
Inclusion and exclusion criteria
Description

Inclusion and exclusion criteria

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0680251
This study included fifty-eight women who were undergoing clinical evaluation for recurrent pregnancy loss at the University of Chicago. These women underwent endometrial biopsies as part of the clinical evaluation. From the endometrial biopsies we collected gene expression data and from a blood draw DNA was collected. The women in the study were between the ages of 26 and 43 years and had at least two previous pregnancy losses before10 weeks gestation. Of the original fifty-eight women, fifty-two (90%) were of European ancestry, two (3%) were of Asian ancestry, and four (7%) were of African ancestry.
Description

This study included fifty-eight women who were undergoing clinical evaluation for recurrent pregnancy loss at the University of Chicago. These women underwent endometrial biopsies as part of the clinical evaluation. From the endometrial biopsies we collected gene expression data and from a blood draw DNA was collected. The women in the study were between the ages of 26 and 43 years and had at least two previous pregnancy losses before10 weeks gestation. Of the original fifty-eight women, fifty-two (90%) were of European ancestry, two (3%) were of Asian ancestry, and four (7%) were of African ancestry.

Data type

boolean

Alias
UMLS CUI [1,1]
C0947630
UMLS CUI [1,2]
C1512693
UMLS CUI [1,3]
C0043210
UMLS CUI [1,4]
C4084924
UMLS CUI [1,5]
C2921106
UMLS CUI [2,1]
C1510477
UMLS CUI [2,2]
C0017262
UMLS CUI [2,3]
C0190979
UMLS CUI [2,4]
C0012854
UMLS CUI [3,1]
C0001779
UMLS CUI [3,2]
C0687675
UMLS CUI [3,3]
C0032979
UMLS CUI [4,1]
C1257905
UMLS CUI [4,2]
C1257906
UMLS CUI [4,3]
C1257891
DNA were genotyped with the Affymetrix Axiom Genome-Wide CEU 1 Array at the UCSF Genomics Core Facility. After quality control which included the removal of 4,922 SNPs with <95% genotype call rates, 503 SNPs with Hardy-Weinberg P-values ≤0.001, 336 non-autosomal SNPs, and 252,872 SNPs with minor allele frequencies <0.10, there were 370,008 SNPs remaining. Five women were excluding due to failed quality control of gene expression data and two women were excluded due to low call rates during genotyping. The remaining 53 subjects with both high quality expression and genotype data (49 European ancestry, 2 Asian ancestry, 2 African American ancestry) had SNP call rates >97%
Description

DNA were genotyped with the Affymetrix Axiom Genome-Wide CEU 1 Array at the UCSF Genomics Core Facility. After quality control which included the removal of 4,922 SNPs with <95% genotype call rates, 503 SNPs with Hardy-Weinberg P-values ≤0.001, 336 non-autosomal SNPs, and 252,872 SNPs with minor allele frequencies <0.10, there were 370,008 SNPs remaining. Five women were excluding due to failed quality control of gene expression data and two women were excluded due to low call rates during genotyping. The remaining 53 subjects with both high quality expression and genotype data (49 European ancestry, 2 Asian ancestry, 2 African American ancestry) had SNP call rates >97%

Data type

boolean

Alias
UMLS CUI [1,1]
C0012854
UMLS CUI [1,2]
C1285573
UMLS CUI [1,3]
C4085938
UMLS CUI [1,4]
C5239481
UMLS CUI [1,5]
C1707515
UMLS CUI [2,1]
C0034378
UMLS CUI [2,2]
C0752046
UMLS CUI [2,3]
C1881032
UMLS CUI [2,4]
C0017270
UMLS CUI [3,1]
C0043210
UMLS CUI [3,2]
C2828389
UMLS CUI [3,3]
C0034378
UMLS CUI [3,4]
C5200924
UMLS CUI [3,5]
C0017262
UMLS CUI [4,1]
C1257905
UMLS CUI [4,2]
C1257906
UMLS CUI [4,3]
C4540921
Back to the top of the page

Similar models

Eligibility Criteria

5 forms
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. Subject ID and consent group of participants in mid-secretory endometrium, corresponding to the luteal phase of the ovarian cycle and involved in the "Expression Quantitative Trait Locus Mapping Studies in Mid-Secretory Phase Endometrial Cells Identifies HLA-F and TAP2 as Fecundability-Associated Genes" project.
    3. Subject ID, sample ID, and sample use variable obtained from participants in mid-secretory endometrium, corresponding to the luteal phase of the ovarian cycle and involved in the "Expression Quantitative Trait Locus Mapping Studies in Mid-Secretory Phase Endometrial Cells Identifies HLA-F and TAP2 as Fecundability-Associated Genes" project.
    4. Subject ID, age, BMI, race, number of previous miscarriages at time of endometrial biopsy, and time of year of endometrial biopsy of participants in mid-secretory endometrium, corresponding to the luteal phase of the ovarian cycle and involved in the "Expression Quantitative Trait Locus Mapping Studies in Mid-Secretory Phase Endometrial Cells Identifies HLA-F and TAP2 as Fecundability-Associated Genes" project.
    5. Sample ID, genotyping center, body site where sample was obtained, analyte type, and tumor status of samples obtained from participants in mid-secretory endometrium, corresponding to the luteal phase of the ovarian cycle and involved in the "Expression Quantitative Trait Locus Mapping Studies in Mid-Secretory Phase Endometrial Cells Identifies HLA-F and TAP2 as Fecundability-Associated Genes" project.
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inclusion and exclusion criteria
C1512693 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
This study included fifty-eight women who were undergoing clinical evaluation for recurrent pregnancy loss at the University of Chicago. These women underwent endometrial biopsies as part of the clinical evaluation. From the endometrial biopsies we collected gene expression data and from a blood draw DNA was collected. The women in the study were between the ages of 26 and 43 years and had at least two previous pregnancy losses before10 weeks gestation. Of the original fifty-eight women, fifty-two (90%) were of European ancestry, two (3%) were of Asian ancestry, and four (7%) were of African ancestry.
Item
This study included fifty-eight women who were undergoing clinical evaluation for recurrent pregnancy loss at the University of Chicago. These women underwent endometrial biopsies as part of the clinical evaluation. From the endometrial biopsies we collected gene expression data and from a blood draw DNA was collected. The women in the study were between the ages of 26 and 43 years and had at least two previous pregnancy losses before10 weeks gestation. Of the original fifty-eight women, fifty-two (90%) were of European ancestry, two (3%) were of Asian ancestry, and four (7%) were of African ancestry.
boolean
C0947630 (UMLS CUI [1,1])
C1512693 (UMLS CUI [1,2])
C0043210 (UMLS CUI [1,3])
C4084924 (UMLS CUI [1,4])
C2921106 (UMLS CUI [1,5])
C1510477 (UMLS CUI [2,1])
C0017262 (UMLS CUI [2,2])
C0190979 (UMLS CUI [2,3])
C0012854 (UMLS CUI [2,4])
C0001779 (UMLS CUI [3,1])
C0687675 (UMLS CUI [3,2])
C0032979 (UMLS CUI [3,3])
C1257905 (UMLS CUI [4,1])
C1257906 (UMLS CUI [4,2])
C1257891 (UMLS CUI [4,3])
DNA were genotyped with the Affymetrix Axiom Genome-Wide CEU 1 Array at the UCSF Genomics Core Facility. After quality control which included the removal of 4,922 SNPs with <95% genotype call rates, 503 SNPs with Hardy-Weinberg P-values ≤0.001, 336 non-autosomal SNPs, and 252,872 SNPs with minor allele frequencies <0.10, there were 370,008 SNPs remaining. Five women were excluding due to failed quality control of gene expression data and two women were excluded due to low call rates during genotyping. The remaining 53 subjects with both high quality expression and genotype data (49 European ancestry, 2 Asian ancestry, 2 African American ancestry) had SNP call rates >97%
Item
DNA were genotyped with the Affymetrix Axiom Genome-Wide CEU 1 Array at the UCSF Genomics Core Facility. After quality control which included the removal of 4,922 SNPs with <95% genotype call rates, 503 SNPs with Hardy-Weinberg P-values ≤0.001, 336 non-autosomal SNPs, and 252,872 SNPs with minor allele frequencies <0.10, there were 370,008 SNPs remaining. Five women were excluding due to failed quality control of gene expression data and two women were excluded due to low call rates during genotyping. The remaining 53 subjects with both high quality expression and genotype data (49 European ancestry, 2 Asian ancestry, 2 African American ancestry) had SNP call rates >97%
boolean
C0012854 (UMLS CUI [1,1])
C1285573 (UMLS CUI [1,2])
C4085938 (UMLS CUI [1,3])
C5239481 (UMLS CUI [1,4])
C1707515 (UMLS CUI [1,5])
C0034378 (UMLS CUI [2,1])
C0752046 (UMLS CUI [2,2])
C1881032 (UMLS CUI [2,3])
C0017270 (UMLS CUI [2,4])
C0043210 (UMLS CUI [3,1])
C2828389 (UMLS CUI [3,2])
C0034378 (UMLS CUI [3,3])
C5200924 (UMLS CUI [3,4])
C0017262 (UMLS CUI [3,5])
C1257905 (UMLS CUI [4,1])
C1257906 (UMLS CUI [4,2])
C4540921 (UMLS CUI [4,3])
Back to the top of the page